CCC12CN3CC(CC)(CN(C1)C3c1ccc([N+](=O)[O-])o1)C2=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?